The board of directors of WuXi Biologics (Cayman) Inc. announced that Dr. Weichang Zhou has been appointed as a member of the strategy committee of the company by the Board with effect from August 17, 2022. Since joining the Group in 2012, Dr. Zhou has built and led a world-class global biologics development team with more than 4,500 scientists with leading capabilities and capacities in diversified platforms. Under his leadership, the team has innovated breakthrough proprietary biologics technology platforms and expanded capabilities to drive the Group's rapid business growth and overall development. Biographical details of Dr. Zhou are set out in the Company's annual report for the year ended December 31, 2021.

As at the date of this announcement, the Strategy Committee comprises Dr. Zhisheng Chen (chairman), Dr. Ge Li, Mr. Yibing Wu and Dr. Zhou.